187 related articles for article (PubMed ID: 22193624)
1. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
Jaiswal PK; Goel A; Mandhani A; Mittal RD
Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
[TBL] [Abstract][Full Text] [Related]
2. Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population.
Jaiswal PK; Goel A; Mittal RD
Biosci Trends; 2011; 5(5):205-10. PubMed ID: 22101376
[TBL] [Abstract][Full Text] [Related]
3. Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population.
Jaiswal PK; Singh V; Srivastava P; Mittal RD
Gene; 2013 Apr; 519(1):128-34. PubMed ID: 23403235
[TBL] [Abstract][Full Text] [Related]
4. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
5. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
6. Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.
Singh V; Srivastava P; Srivastava N; Kapoor R; Mittal RD
Mol Biol Rep; 2012 Oct; 39(10):9827-34. PubMed ID: 22733495
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.
Jaiswal PK; Singh V; Mittal RD
Mol Biol Rep; 2014 Feb; 41(2):799-807. PubMed ID: 24390231
[TBL] [Abstract][Full Text] [Related]
8. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
[TBL] [Abstract][Full Text] [Related]
9. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians.
Singh V; Jaiswal PK; Mittal RD
Urol Oncol; 2014 Nov; 32(8):1209-14. PubMed ID: 25218484
[TBL] [Abstract][Full Text] [Related]
10. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
[TBL] [Abstract][Full Text] [Related]
11. Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk.
Jaiswal PK; Tripathi N; Shukla A; Mittal RD
Med Oncol; 2013 Jun; 30(2):509. PubMed ID: 23430447
[TBL] [Abstract][Full Text] [Related]
12. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
Mittal RD; Mandal RK; Gangwar R
Mech Ageing Dev; 2012 Apr; 133(4):127-32. PubMed ID: 22019847
[TBL] [Abstract][Full Text] [Related]
13. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
[TBL] [Abstract][Full Text] [Related]
14. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
[TBL] [Abstract][Full Text] [Related]
15. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
Javid J; Mir R; Julka PK; Ray PC; Saxena A
Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
[TBL] [Abstract][Full Text] [Related]
16. BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
Hmeljak J; Erčulj N; Dolžan V; Kern I; Cör A
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1641-51. PubMed ID: 21861135
[TBL] [Abstract][Full Text] [Related]
17. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
[TBL] [Abstract][Full Text] [Related]
18. Impact of chemokines CCR5∆32, CXCL12G801A, and CXCR2C1208T on bladder cancer susceptibility in north Indian population.
Singh V; Jaiswal PK; Kapoor R; Kapoor R; Mittal RD
Tumour Biol; 2014 May; 35(5):4765-72. PubMed ID: 24430363
[TBL] [Abstract][Full Text] [Related]
19. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
[TBL] [Abstract][Full Text] [Related]
20. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
